Elanco Animal Health (NYSE: ELAN) officer uses 4,392 shares for tax withholding

Rhea-AI Filing Summary

Elanco Animal Health Inc officer Rajeev A. Modi reported a tax-related share disposition. On 2026-03-03, he disposed of 4,392 shares of common stock through a tax-withholding disposition at $24.88 per share, leaving 155,901 shares held with direct ownership after the transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Modi Rajeev A.

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		4,392	D	$24.88	155,901	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation

	/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Elanco (ELAN) officer Rajeev A. Modi report in this Form 4 filing?

Rajeev A. Modi reported a tax-withholding disposition of Elanco Animal Health Inc common stock. He disposed of 4,392 shares on 2026-03-03 at $24.88 per share to satisfy tax obligations by delivering securities.

How many Elanco (ELAN) shares did Rajeev A. Modi dispose of for taxes?

Rajeev A. Modi disposed of 4,392 shares of Elanco common stock. The transaction was reported with code “F,” indicating payment of a tax liability by delivering securities rather than an open-market sale, according to the Form 4 details.

At what price were Rajeev A. Modi’s Elanco (ELAN) shares used for tax withholding?

The 4,392 shares disposed of for tax withholding were valued at $24.88 per share. This price is disclosed as the transaction price per share for the common stock in the non-derivative transaction reported on 2026-03-03.

How many Elanco (ELAN) shares does Rajeev A. Modi hold after this Form 4 transaction?

After the reported tax-withholding disposition, Rajeev A. Modi directly holds 155,901 shares of Elanco Animal Health Inc common stock. The Form 4 lists this figure as the total shares beneficially owned following the non-derivative transaction.

What does transaction code "F" mean in Rajeev A. Modi’s Elanco (ELAN) Form 4?

Transaction code “F” indicates payment of a tax liability by delivering securities. In this Form 4, the 4,392 Elanco common shares were disposed of as a tax-withholding disposition rather than as a standard open-market purchase or sale.

Is Rajeev A. Modi’s ownership in Elanco (ELAN) classified as direct or indirect after the transaction?

Rajeev A. Modi’s remaining 155,901 Elanco shares are classified as direct ownership. The Form 4 marks the ownership code as “D,” indicating that the reported holdings are directly owned rather than held through an intermediate entity.